BPG is committed to discovery and dissemination of knowledge
Retrospective Cohort Study
©The Author(s) 2025.
World J Clin Cases. Nov 16, 2025; 13(32): 110553
Published online Nov 16, 2025. doi: 10.12998/wjcc.v13.i32.110553
Table 2 Outcomes of endoscopic retrograde cholangiopancreatography, n (%)
Variables
AC with ABP, n = 90
AC without ABP, n = 268
P value
Time to ERCP in hours
Overall population45.4 (30.4-69.3)62.6 (26.0-83.1)0.030
    Mild AC42.1 (18.4-71.8)46.3 (28.6-84.0)0.243
    Moderate AC35.9 (19.5-57.6)46.6 (28.9-76.4)0.029
    Severe AC63.4 (28.6-91.8)67.5 (28.8-94.6)0.538
ERCP procedure
    Successful biliary cannulation90 (100)264 (98.5)0.244
Papillary procedures, n = 354
    EST89 (98.9)253 (94.4)0.167
    EPBD0 4 (1.5)0.241
    No EST or EPBD1 (1.1)10 (3.7)0.206
Bile duct sweep, n = 34186 (95.6)255 (95.1)0.844
    With stones72/86 (83.7)230/255 (90.2)0.103
    Without stones14/86 (16.3)25/255 (9.8)0.103
Stent insertion5 (5.6)23 (8.6)0.338
Adverse event due to ERCP5 (5.6)14 (5.2)0.921
    Delayed bleeding2 (2.2)6 (2.2)0.982
    Pancreatitis06 (1.9)0.344
    AC2 (2.2)1 (0.4)0.159
    Perforation2 (2.2)1 (0.4)0.159


Write to the Help Desk